In 2023, the actual number of tuberculosis-related deaths (excluding HIV cases) in France stood at approximately 385. The forecasted data indicates a gradual decline, with deaths projected at 377 in 2024, decreasing each subsequent year to reach 347 by 2028. This represents a steady year-on-year decline averaging around 2.0%. The compound annual growth rate (CAGR) over this five-year period is approximately -2.0%, suggesting consistent progress in managing this public health challenge.
Future trends to watch for include the impact of emerging healthcare technologies and policies on tuberculosis prevention and treatment. Additionally, monitoring shifts in population health demographics and continued investment in medical research will be crucial to further reducing mortality rates.
